keyword
https://read.qxmd.com/read/38652836/an-analysis-of-the-effects-of-chronic-low-dose-rate-radiation-exposure-on-cancer-focusing-on-the-differences-among-cancer-types
#1
JOURNAL ARTICLE
Tetsuhiro Kinugawa, Ignacia Braga Tanaka, Satoshi Tanaka, Yuichiro Manabe, Fuminobu Sato, Takahiro Wada
PURPOSE: The effect of chronic low dose-rate radiation exposure on cancers was investigated by analyzing the data of mice experiments conducted at the Institute for Environmental Sciences (IES). This analysis focuses on the differences between malignant lymphomas and solid cancers. MATERIALS AND METHODS: The analysis is conducted based on the mathematical model introduced in our previous work. The model is expanded to analyze malignant lymphomas and solid cancers separately...
April 23, 2024: International Journal of Radiation Biology
https://read.qxmd.com/read/38652827/in-vitro-evaluation-of-the-carcinogenic-potential-of-perfluorinated-chemicals
#2
JOURNAL ARTICLE
Monica Vaccari, Stefania Serra, Andrea Ranzi, Federico Aldrovandi, Giangabriele Maffei, Maria G Mascolo, Ada Mescoli, Elisa Montanari, Gelsomina Pillo, Francesca Rotondo, Ivan Scaroni, Lorenzo Vaccari, Cristina Zanzi, Tony Fletcher, Martin Paparella, Annamaria Colacci
Perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) are the major components of long-chain per- and polyfluorinated alkyl substances (PFAS), known for their chemical stability and environmental persistence. Even if PFOA and PFOS have been phased out or are limited in use, they still represent a concern for human and environmental health. Several studies have been performed to highlight the toxicological behavior of these chemicals and their mode of action (MoA). Data suggested the causal association between PFOA or PFOS exposure and carcinogenicity in humans, but the outcomes of epidemiological studies showed some inconsistency...
April 22, 2024: ALTEX
https://read.qxmd.com/read/38652741/decorin-suppresses-tumor-lymphangiogenesis-a-mechanism-to-curtail-cancer-progression
#3
JOURNAL ARTICLE
Dipon K Mondal, Christopher Xie, Gabriel J Pascal, Simone Buraschi, Renato V Iozzo
The complex interplay between malignant cells and the cellular and molecular components of the tumor stroma is a key aspect of cancer growth and development. These tumor-host interactions are often affected by soluble bioactive molecules such as proteoglycans. Decorin, an archetypical small leucine-rich proteoglycan primarily expressed by stromal cells, affects cancer growth in its soluble form by interacting with several receptor tyrosine kinases (RTK). Overall, decorin leads to a context-dependent and protracted cessation of oncogenic RTK activity by attenuating their ability to drive a prosurvival program and to sustain a proangiogenic network...
April 30, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38652676/flt3-agonists-and-secondary-hematopoietic-malignancies-a-potential-class-effect
#4
JOURNAL ARTICLE
Henry W Raeder, Michael W Drazer
Expansion of cDC cells via FLT3 agonism has promising therapeutic potential in the treatment of advanced solid tumors. Here, we discuss the results of a clinical trial using GS-3583, an FLT3 agonist, that was stopped after a patient in the study developed acute myeloid leukemia.
April 23, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38652547/multi-omics-characterization-of-esophageal-squamous-cell-carcinoma-identifies-molecular-subtypes-and-therapeutic-targets
#5
JOURNAL ARTICLE
Dengyun Zhao, Yaping Guo, Huifang Wei, Xuechao Jia, Yafei Zhi, Guiliang He, Wenna Nie, Limeng Huang, Penglei Wang, Kyle Vaughn Laster, Zhicai Liu, Jinwu Wang, Mee-Hyun Lee, Zigang Dong, Kangdong Liu
Esophageal squamous cell carcinoma (ESCC) is the predominant form of esophageal cancer and is characterized by an unfavorable prognosis. To elucidate the distinct molecular alterations in ESCC and investigate therapeutic targets, we performed a comprehensive analysis of transcriptomic, proteomic, and phosphoproteomic data derived from 60 paired treatment-naive ESCC and adjacent non-tumor tissue samples. Additionally, we conducted a correlation analysis to describe the regulatory relationship between transcriptomic and proteomic processes, revealing alterations in key metabolic pathways...
April 23, 2024: JCI Insight
https://read.qxmd.com/read/38652518/is-a-low-dose-of-dexamethasone-sufficient-to-prevent-paclitaxel-related-hypersensitivity-reactions-a-retrospective-study-in-patients-with-gynecologic-malignancy
#6
JOURNAL ARTICLE
Di Xiao, Zhiyun Yang, Yin Shi, Wenqing Yang, Yu Zhang
BACKGROUND: Paclitaxel hypersensitivity reactions (HSRs) are prevalent, especially in females. The common paclitaxel pretreatment, dexamethasone, may inhibit chemotherapy efficacy and accelerate tumor progression. We aimed to balance paclitaxel HSRs and the lowest dexamethasone dose for gynecologic malignancies. METHODS: We retrospectively examined 1,074 cycles of 3-weekly paclitaxel-containing treatment for 231 gynecologic malignancies at Xiangya Hospital. HSR incidence with different dexamethasone regimens was the primary outcome...
April 23, 2024: Expert Review of Clinical Pharmacology
https://read.qxmd.com/read/38652458/improving-supportive-palliative-and-end-of-life-care-for-teenagers-and-young-adults-with-cancer-in-adult-haematology-services
#7
JOURNAL ARTICLE
Claire Lewis-Norman, Jennifer Vidrine, Emma Thistlethwayte
PURPOSE OF REVIEW: Adolescents with haematological malignancies within adult services, in the UK from 16 years old, have unique needs and require developmentally targeted services and approaches to care delivery. High-risk intensive treatments are common for this cohort and a better understanding of what individualised supportive and palliative care means in this context is required. RECENT FINDINGS: Being known and understood as an emerging adult, with particular recognition of developmental stage, is an essential component of quality measures and underpins the adolescent, and caregiver, experience when faced with an uncertain or poor cancer prognosis (UPCP)...
April 23, 2024: Current Opinion in Supportive and Palliative Care
https://read.qxmd.com/read/38652455/supportive-care-measures-for-bispecific-t-cell-engager-therapies-in-haematological-malignancies
#8
JOURNAL ARTICLE
Lucia Y Chen, Jaimal Kothari
PURPOSE OF REVIEW: Bispecific T-cell engager (TCE) therapies are revolutionizing the treatment of several haematological malignancies, including B-cell acute lymphoblastic leukaemia, various subtypes of B-cell non-Hodgkin lymphoma, and multiple myeloma. Due to their unique mode of action in activating endogenous T cells, they are associated with several important early side effects, including cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome, as well as target-specific toxicities and a significant risk of infection...
April 23, 2024: Current Opinion in Supportive and Palliative Care
https://read.qxmd.com/read/38652426/antibody-drug-conjugates-in-urological-cancers-a-review-of-the-current-landscape
#9
REVIEW
Aruni Ghose, Patricia Lapitan, Vedika Apte, Adheesh Ghosh, Abhinav Kandala, Sreejana Basu, Jo Parkes, Sayali D Shinde, Stergios Boussios, Anand Sharma, Prantik Das, Nikhil Vasdev, Sara E Rebuzzi, Yüksel Ürün, Ravindran Kanesvaran, Akash Maniam, Giuseppe L Banna
PURPOSE OF REVIEW: Our review delves into the progress across urological malignancies and discusses ongoing challenges and future directions in antibody-drug conjugate (ADC) development, emphasising their transformative potential in cancer care. RECENT FINDINGS: ADCs have advanced from hematologic to solid tumours, notably in breast cancer, and are now pivotal in metastatic urological cancers as both monotherapies and in combination regimens, underscored by the FDA's approval of enfortumab vedotin and sacituzumab govitecan for metastatic urothelial cancer...
April 23, 2024: Current Oncology Reports
https://read.qxmd.com/read/38652340/poorly-differentiated-mucinous-carcinoma-of-the-ascending-colon-complicated-by-bilateral-ovarian-mature-cystic-teratomas-in-a-17-year-old-female-patient-a-case-report
#10
JOURNAL ARTICLE
Takuya Shimogawa, Yukiharu Hiyoshi, Mayuko Ouchi, Keisuke Kosumi, Kojiro Eto, Satoshi Ida, Masaaki Iwatsuki, Yoshifumi Baba, Yuji Miyamoto, Nasa Okazaki, Yuko Miyasato, Hideo Baba
BACKGROUND: Colorectal cancer (CRC) is one of the most common cancers worldwide, and screening colonoscopy has led to a decreasing incidence rate. However, the incidence of CRC is increasing among young people, especially adolescents and young adults (AYAs) who are not routinely screened. Although CRC is the fourth most common cancer among AYAs, it is extremely rare. In younger patients, CRC is often diagnosed later, and the proportion of patients with advanced CRC is higher than that in older patients...
April 23, 2024: Surgical Case Reports
https://read.qxmd.com/read/38652317/oral-mucosa-an-examination-map-for-confocal-laser-endomicroscopy-within-the-oral-cavity-an-experimental-clinical-study
#11
JOURNAL ARTICLE
Nicolai Oetter, Jonas Pröll, Matti Sievert, Miguel Goncalves, Maximilian Rohde, Christopher-Philipp Nobis, Christian Knipfer, Marc Aubreville, Zhaoya Pan, Katharina Breininger, Andreas Maier, Marco Kesting, Florian Stelzle
OBJECTIVES: Confocal laser endomicroscopy (CLE) is an optical method that enables microscopic visualization of oral mucosa. Previous studies have shown that it is possible to differentiate between physiological and malignant oral mucosa. However, differences in mucosal architecture were not taken into account. The objective was to map the different oral mucosal morphologies and to establish a "CLE map" of physiological mucosa as baseline for further application of this powerful technology...
April 23, 2024: Clinical Oral Investigations
https://read.qxmd.com/read/38652307/-precision-oncology-and-molecular-tumor-boards
#12
JOURNAL ARTICLE
Elisabeth Mack, Peter Horak, Stefan Fröhling, Andreas Neubauer
Precision oncology is a field of personalized medicine in which tumor biology forms the basis for tailored treatments. The preferred approach currently applied in clinical practice is based on the concept of malignant tumors as genetic diseases that are caused by mutations in oncogenes and tumor suppressors. On the one hand, these can be targeted by molecular drugs, while on the other hand, next-generation sequencing allows for comprehensive analysis of all relevant aberrations, thus enabling the matching of appropriate treatments across entities based on molecular information...
April 23, 2024: Inn Med (Heidelb)
https://read.qxmd.com/read/38652301/diagnostic-accuracy-of-artificial-intelligence-assisted-clinical-imaging-in-the-detection-of-oral-potentially-malignant-disorders-and-oral-cancer-a-systematic-review-and-meta-analysis
#13
JOURNAL ARTICLE
JingWen Li, Wai Ying Kot, Colman Patrick McGrath, Bik Wan Amy Chan, Joshua Wing Kei Ho, Li Wu Zheng
BACKGROUND: The objective of this study is to examine the application of AI algorithms in detecting OPMD and oral cancerous lesions, and to evaluate the accuracy variations among different imaging tools employed in these diagnostic processes. MATERIALS AND METHODS: A systematic search was conducted in four databases: Embase, Web of Science, PubMed, and Scopus. The inclusion criteria included studies using machine learning algorithms to provide diagnostic information on specific oral lesions, prospective or retrospective design, and inclusion of OPMD...
April 23, 2024: International Journal of Surgery
https://read.qxmd.com/read/38652298/to-trust-or-not-to-trust-evaluating-the-reliability-and-safety-of-ai-responses-to-laryngeal-cancer-queries
#14
JOURNAL ARTICLE
Magdalena Ostrowska, Paulina Kacała, Deborah Onolememen, Katie Vaughan-Lane, Anitta Sisily Joseph, Adam Ostrowski, Wioletta Pietruszewska, Jacek Banaszewski, Maciej J Wróbel
PURPOSE: As online health information-seeking surges, concerns mount over the quality and safety of accessible content, potentially leading to patient harm through misinformation. On one hand, the emergence of Artificial Intelligence (AI) in healthcare could prevent it; on the other hand, questions raise regarding the quality and safety of the medical information provided. As laryngeal cancer is a prevalent head and neck malignancy, this study aims to evaluate the utility and safety of three large language models (LLMs) as sources of patient information about laryngeal cancer...
April 23, 2024: European Archives of Oto-rhino-laryngology
https://read.qxmd.com/read/38652224/anti-spike-antibody-level-is-associated-with-the-risk-of-clinical-progression-among-subjects-hospitalized-with-covid-19-pneumonia-results-from-a-retrospective-cohort-study
#15
JOURNAL ARTICLE
Giuseppe Lapadula, Luca Mezzadri, Giustina Lo Cascio, Laura Antolini, Sergio Malandrin, Alice Ranzani, Silvia Limonta, Annalisa Cavallero, Paolo Bonfanti
PURPOSE: Antibodies against SARS-CoV-2 spike (anti-S) may confer protection against symptomatic COVID-19. Whether their level predicts progression among those with COVID-19 pneumonia remains unclear. METHODS: We conducted a retrospective cohort study to assess predictors of anti-S levels and whether anti-S titer is associated with death or mechanical ventilation (MV). Adults hospitalized for COVID-19 pneumonia between July 2021 and July 2022 were enrolled if anti-S had been measured within 72 h of admission...
April 23, 2024: Infection
https://read.qxmd.com/read/38652222/chordoma-cells-possess-bone-dissolving-activity-at-the-bone-invasion-front
#16
JOURNAL ARTICLE
Katsuhiro Kawaai, Yumiko Oishi, Yukiko Kuroda, Ryota Tamura, Masahiro Toda, Koichi Matsuo
PURPOSE: Chordomas are malignant tumors that destroy bones, compress surrounding nerve tissues and exhibit phenotypes that recapitulate notochordal differentiation in the axial skeleton. Chordomas recur frequently, as they resist radio-chemotherapy and are difficult to completely resect, leading to repeated bone destruction and local expansion via unknown mechanisms. Here, using chordoma specimens and JHC7 chordoma cells, we asked whether chordoma cells possess bone-dissolving activity...
April 23, 2024: Cellular Oncology (Dordrecht)
https://read.qxmd.com/read/38652196/clinical-utility-of-the-combined-use-of-ca19-9-and-dupan-2-in-pancreatic-adenocarcinoma
#17
JOURNAL ARTICLE
Tatsuaki Sumiyoshi, Kenichiro Uemura, Ryuta Shintakuya, Kenjiro Okada, Kenta Baba, Takumi Harada, Masahiro Serikawa, Yasutaka Ishii, Shinya Nakamura, Koji Arihiro, Yoshiaki Murakami, Shinya Takahashi
PURPOSE: Pancreatic ductal adenocarcinoma (PDAC) patients with normal carbohydrate antigen (CA) 19-9 levels can have early-stage cancer or advanced cancer without elevation of CA19-9 level; estimating their malignant potential is difficult. This study investigated the clinical utility of the combined use of preoperative CA 19-9 and Duke pancreatic monoclonal antigen type 2 (DUPAN-2) levels in patients with PDAC. METHODS: Patients who underwent curative-intent surgery for PDAC between November 2005 and December 2021 were investigated...
April 23, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38652192/bortezomib-suppresses-acute-myelogenous-leukaemia-stem-like-kg-1a-cells-via-nf-%C3%AE%C2%BAb-inhibition-and-the-induction-of-oxidative-stress
#18
JOURNAL ARTICLE
Rafaela G A Costa, Maiara de S Oliveira, Ana Carolina B da C Rodrigues, Suellen L R Silva, Ingrid R S B Dias, Milena B P Soares, Ludmila de Faro Valverde, Clarissa Araujo Gurgel Rocha, Rosane Borges Dias, Daniel P Bezerra
Acute myelogenous leukaemia (AML) originates and is maintained by leukaemic stem cells (LSCs) that are inherently resistant to antiproliferative therapies, indicating that a critical strategy for overcoming chemoresistance in AML therapy is to eradicate LSCs. In this work, we investigated the anti-AML activity of bortezomib (BTZ), emphasizing its anti-LSC potential, using KG-1a cells, an AML cell line with stem-like properties. BTZ presented potent cytotoxicity to both solid and haematological malignancy cells and reduced the stem-like features of KG-1a cells, as observed by the reduction in CD34- and CD123-positive cells...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38652093/identification-of-ppar-related-differentially-expressed-genes-liver-hepatocellular-carcinoma-and-construction-of-a-prognostic-model-based-on-data-analysis-and-molecular-docking
#19
JOURNAL ARTICLE
Yumeng Wang, Shuqiang Li, Zihang Liu, Xuanzheng Li, Yifan Yu, Hao Liu
Liver hepatocellular carcinoma (LIHC) is a significant global health issue with limited treatment options. In this study, single-cell RNA sequencing (scRNA-seq) data were used to explore the molecular mechanisms of LIHC development and identify potential targets for therapy. The expression of peroxisome proliferator-activated receptors (PPAR)-related genes was analysed in LIHC samples, and primary cell populations, including natural killer cells, T cells, B cells, myeloid cells, endothelial cells, fibroblasts and hepatocytes, were identified...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38652051/outcomes-of-referrals-in-pediatric-patients-with-peripheral-lymphadenopathy
#20
JOURNAL ARTICLE
Kathryn A Six, Inmaculada B Aban, Gabriel M Daniels, Julie Wolfson, Elizabeth A Beierle, Matthew A Kutny, Jeffrey Lebensburger, Ana C Xavier
Lymphadenopathy is a common reason for referral to a subspecialist, which may result in significant anxiety for parents. Understanding which patients require a subspecialty referral for lymphadenopathy is key to streamlining health care utilization for this common clinical entity. This is an IRB-approved retrospective study examining pediatric patients consecutively referred to pediatric hematology oncology, otolaryngology, or surgery for lymphadenopathy from 2012 to 2021 at a free-standing tertiary-care children's hospital...
April 23, 2024: Journal of Pediatric Hematology/oncology
keyword
keyword
81531
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.